LivingGLP1
Study S002531

Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Metabolic Surgery Versus GLP-1 Receptor Agonists

ClinicalTrials.gov record

Registration

Registration
NCT06355219
Acronym
M6
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
3932
Start
2010-01-01
Primary completion
2022-12-31
Lead sponsor
Ali Aminian
Conditions
Type 2 Diabetes Mellitus; Obesity; Microvascular Disease; Macrovascular Disease; Major Adverse Cardiovascular Events; Nephropathy; Retinopathy; Heart Failure; All Cause Mortality
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • All-cause Mortality Rate [After surgical or assigned index date to Dec 31, 2022]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.